CASI PHARMACEUTICALS, INC. Operating Cash Flow
CASI PHARMACEUTICALS, INC. (CASIF) reported Operating Cash Flow of -$20.75 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-15
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2025-12-31 | -$20.75M 20-F · filed 2026-05-15 |
| 2024-12-31 | -$29.22M 20-F · filed 2026-05-15 |
| 2023-12-31 | -$19.97M 20-F · filed 2026-05-15 |
| 2022-12-31 | -$21.09M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$26.84M 20-F · filed 2024-03-28 |
| 2020-12-31 | -$25.89M 20-F · filed 2023-04-26 |